Choroidal Disorders provides an overview on various chorioretinal disorders with a special emphasis on choroidal imaging. As our understanding of the choroid has significantly improved with the development of advanced optical coherence tomography (OCT) and its role in posterior segment diseases is gaining new significance, this book focuses on the related improvements, diagnostic capabilities, management and prognosis of various chorioretinal disorders. It covers conventional techniques, such as ultrasonography and indocyanine green angiography as well as the most advanced techniques, including enhanced depth imaging OCT, swept source OCT, and OCT angiography. - Concise overview of various chorioretinal disorders, with special emphasis on choroidal imaging - Written for practitioners and researchers in sensory systems (vision), ophthalmologists, and retina specialists - Covers the most advanced imaging techniques in choroidal disorders, such as enhanced depth imaging OCT, swept source OCT, and OCT angiography
Age-related macular degeneration (AMD) is a disease that causes loss of vision and can lead to central blindness in some patients. Loss of vision from AMD is permanent and has a significant impact on an individual's functioning and quality of life. Currently, there are no effective treatments for the majority of individuals with AMD. Verteporfin photodynamic therapy (PDT) a new treatment for "wet" AMD, the type of AMD responsible for more pronounced vision loss. Evidence from three high-quality RCTs suggests that, compared with placebo, verteporfin PDT treatment for two years reduces the number of cases of central blindness. However, these results apply to a study population with subfoveal neovascularization from AMD, and only a minority of these individuals is likely to qualify for treatment after diagnosis and angiographic assessment. Verteporfin PDT is likely to increase the need for angiographic screening. Treatment is not aimed at restoring vision and the majority of treated individuals will continue to lose visual acuity. Compared to placebo (angiography and sham treatment), verteporfin did not cause an overall increase in serious adverse events and appears to be reasonably well tolerated. The direct impact of this treatment on quality of life and visual function is not known. The two-year incremental costs for this procedure in Canada based on RCT evidence are estimated to be between $10,625 and $14,250.
Rapid or even dramatic progress has been made in the field of AMD over recent years, leading to a constant revision of basic concepts. A wide range of fundus imaging modalities are now available, and this book explains the respective value of each technique. The information provided by OCT is presented logically by comparison with plain films, autofluorescence, fluorescein angiography, or indocyanine green angiography. Meticulous biomicroscopic examination of macular changes and the essential value of fluorescein angiography for the detection of anatomical alterations of the macula and for precise evaluation of lesions and their course by indocyanine green angiography have naturally led the author Gabriel Coscas to analyze the new data provided by OCT.
Pathologic Myopia is a major cause of severe vision loss worldwide. The mechanisms for vision loss include cataract, glaucoma, retinal detachment, and above all, myopic maculopathy within the posterior staphyloma. The first edition of Pathologic Myopia is one of the only current books to specifically address this disease and discusses recent developments in imaging technologies and various approaches to treatments, such as laser photocoagulation, photodynamic therapy, pharmaco-therapeutic injections in the vitreous, and surgery. This new edition is a timely update to the standard reference in the field, with new chapters on advanced refractive error correction, genetics, developing a classification system, and special surgical approaches for pathologic myopia. Complete with even more high-quality color images and informative tables, this book is written and edited by leaders in the field and is geared towards ophthalmologists, including residents and fellows in training, glaucoma and cataract specialists, and vitreoretinal macula experts.
This is the only text available that is devoted exclusively to the ICG imaging technique, its methods and findings. It provides an invaluable guide to this new diagnostic/research tool.
Written by an international team of ophthalmic practitioners, this authoritative book is a vital resource not only for ophthalmic professionals, but for any healthcare professional who cares for patients with eye problems. In the ten years since the first edition was published, practice has moved on, as has the evidence for practice. This second edition draws on the passion and goodwill of the original team of authors, complemented by other colleagues, to fully revise and update the text in line with new findings, new practice and new and exciting treatments. The book is broadly divided into three sections. The first section considers the structure and function of the eye, as well as the basic principles of ophthalmology and eye examination. The second section considers patient care in diverse settings, as well as work-related issues and patient education. It also includes two entirely new chapters on eye banking and global eye health. The third section takes a systematic approach to patient care, working from the front to the back of the eye, discussing some of the common disorders affecting each structure (such as the lens or cornea) or group of structures (such as the eyelids or lacrimal drainage system). The book concludes with a very useful glossary of ophthalmic terms. Some aspects of practice discussed in the text are, of necessity, UK based, but these are clearly indicated and, wherever possible, principles (rather than specifics) are addressed and readers are directed to local policies and interpretations. The first edition of this book became a core text for ophthalmic nursing, in particular, and for the education of ophthalmic nurses across the world. This new edition will provide a comprehensive, up-to-date, evidence-based resource for all ophthalmic healthcare professionals. Contents include: • Physiology of vision • Optics • Pharmacology • Examination of the eye • Visual impairment • Patient education • Work and the eye • Care of the adult ophthalmic patient in an inpatient setting • The care of the child undergoing ophthalmic treatment • Developments in day care surgery for ophthalmic patients • Ophthalmic theatre nursing • The care of patients presenting with acute problems • Eye banking • Global eye health • The eyelids and lacrimal drainage system • The conjunctiva • The cornea • The sclera • The lens • The uveal tract • The angle and aqueous • The retina and vitreous • The orbit and extraocular muscles • Visual and pupillary pathways and neuro-ophthalmology • The eye and systemic disease
50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.
The use of pharmacotherapeutics in the management of retinal diseases is rapidly evolving, and a favorable therapy for the patient. Today anti-VEGF agents are used for a range of indications from inflammation-related choroidal neovascularization to macular edema secondary to retinal vein occlusion or diabetic retinopathy. Beyond VEGF, there is an array of target areas under investigation – not only for vascular pathologies such as age-related macular degeneration and diabetic eye disease, but also for degenerative, infectious and inflammatory retinal conditions. This publication discusses many aspects from basic research on the retina, to animal models for retinal drug delivery, retinal diseases that are amenable to pharmacotherapy and also drugs and mechanisms in retinal diseases. Anyone concerned with the management of retinal diseases - the general ophthalmologist and the retina specialist alike – will find this book indispensable reading.
